Pregnancy outcomes in women with type 1 diabetes using insulin degludec

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study

(2021) Elisabeth R. Mathiesen et al.   DIABETES CARE

Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study

(2021) Nicoline C. Do et al.   DIABETES CARE

Improving pregnancy outcomes in women with diabetes mellitus: modern management

(2019) Lene Ringholm et al.   Nature Reviews Endocrinology

Treatment with the long-acting insulin analog degludec during pregnancy in women with type 1 diabetes: An observational study of 22 cases

(2019) Maria Fredsgaard Keller et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes

(2019) Marianne Vestgaard et al.   DIABETOLOGIA

Glucose Targets and Insulin Choice in Pregnancy: What Has Changed in the Last Decade?

(2018) Siobhán Bacon et al.   Current Diabetes Reports

Exposure to insulin degludec during pregnancy: report of a small series and review of the literature

(2018) B. M. Bonora et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series

(2018) Siwaporn Hiranput et al.   Diabetes Therapy

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes

(2017) Wendy Lane et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Insulin analogues in pregnancy and specific congenital anomalies: a literature review

(2015) Josta de Jong et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance

(2014) Hanne Haahr et al.   CLINICAL PHARMACOKINETICS

Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial

(2014) M. J. Davies et al.   DIABETES OBESITY & METABOLISM

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) E. R. Seaquist et al.   DIABETES CARE

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN®Basal-Bolus Type 1): 2-year results of a randomized clinical trial

(2013) B. W. Bode et al.   DIABETIC MEDICINE

Hypertension in Pregnancy

(2013)   OBSTETRICS AND GYNECOLOGY

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

(2012) E. R. Mathiesen et al.   DIABETES CARE

Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome

(2012) Nicoline F. Callesen et al.   Journal of Maternal-Fetal & Neonatal Medicine

Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes

(2011) Elisabeth R. Mathiesen et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage

(2011) H. R. Murphy et al.   DIABETIC MEDICINE

Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience

(2008) Annunziata Lapolla et al.   ACTA DIABETOLOGICA